Specific siRNA Targeting Receptor for Advanced Glycation End Products (RAGE) Decreases Proliferation in Human Breast Cancer Cell Lines
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specific siRNA Targeting Receptor for Advanced Glycation End Products (RAGE) Decreases Proliferation in Human Breast Cancer Cell Lines
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 4, Pages 7959-7978
Publisher
MDPI AG
Online
2013-04-12
DOI
10.3390/ijms14047959
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulated Proteolysis of RAGE and AβPP as Possible Link Between Type 2 Diabetes Mellitus and Alzheimer's Disease
- (2017) Elzbieta Kojro et al. JOURNAL OF ALZHEIMERS DISEASE
- The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
- (2012) Al-Madhagi Yaser et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Near-infrared imaging of breast cancer using optical contrast agents
- (2012) Alexander Poellinger Journal of Biophotonics
- Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma
- (2011) Liguo Lin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Chemopreventive Activity of Vitamin E in Breast Cancer: A Focus on γ- and δ-Tocopherol
- (2011) Amanda K. Smolarek et al. Nutrients
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Nuclear NF- B/p65 expression and response to neoadjuvant chemotherapy in breast cancer
- (2010) R. L. Jones et al. JOURNAL OF CLINICAL PATHOLOGY
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
- (2010) Sunil Badve et al. MODERN PATHOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically
- (2009) Andrea Proctor Subhawong et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
- (2009) A. Bierhaus et al. DIABETOLOGIA
- Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response
- (2009) Shi Fang Yan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
- (2008) Jeffrey Peppercorn et al. CANCER INVESTIGATION
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
- (2008) Barry I. Hudson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Letter to the Editor
- (2008) Emad A Rakha et al. MODERN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started